DEFERASIROX相关论文
地拉罗司是用于治疗成人和儿童地中海贫血患者铁超载的一线药物,属于BSC分类第Ⅱ类,在生产过程中应严格控制其原料药(API)的粒度及......
目的 探索术前应用地拉罗司(deferasirox)对大鼠乒乓拍样狭长窄蒂缺氧皮瓣模型微血管生成的促进作用及与用药时间的相关性.方法 成......
目的 探讨地拉罗司对成年大鼠狭长窄蒂皮瓣Delta样配体4(DLL4)、CD105表达及血管新生的影响.方法 健康成年SD大鼠20只随机分为地拉......
目的 探讨地拉罗司能否通过诱导上皮细胞发生间质化改变,从而促进皮瓣微血管生成.方法 雄性成年SD大鼠32只随机均分为Ⅰ组和Ⅱ组......
AIM To evaluate the inhibitory effects of deferasirox(DFX) against hepatocellular carcinoma(HCC) through basic and clini......
目的 模拟体内肌少症病理环境,观察铁螯合剂地拉罗司(deferasirox,DFS)对小鼠成肌细胞C2C12生物学活性的影响。方法 构建模拟体内......
4-hydrazinobenzoic acid has been highlighted as one of the potential genotoxic impurities (PGIs). A sensitive HPLC metho......
4-hydrazinobenzoic acid has been highlighted as one of the potential genotoxic impurities (PGIs). A sensitive HPLC metho......
Efficacy of deferasirox for the treatment of iron overload in a child affected by Juvenile Hemochrom
We report the case of a 7 years old girl with Juvenile Hemochromatosis, due to homozygous mutation of HJV, which had inc......
2004年底在美国圣地亚哥召开的第46届美国血液学协会年会上提交的研究报告显示，Deferasirox(商品名Exjade，ICL670)(Ⅰ)，一种口服每日......
期刊
